Rakuten Medical, Inc. reported raising $5.19 Million in an initial SEC Form D filing, from an offering of $5.19 Million
Amount Raised
$5.19 Million
Round Type
Venture
San MateoBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Aspyrian Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- RevOpsis Therapeutics raised $100K (Pre-Seed) on August 19, 2022.
- Profluent raised $8M on August 19, 2022.
- Kymera raised $150M (Post-IPO Equity) on August 19, 2022.
- AIRS Medical raised $20M (Series B) on August 19, 2022.
- VeraMorph raised $222K (Pre-Seed) on August 19, 2022.
- Arq raised $496K (Pre-Seed) on August 19, 2022.
Who to call at Aspyrian Therapeutics, Inc., and when
A new round usually means Aspyrian Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aspyrian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aspyrian Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aspyrian Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aspyrian Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aspyrian Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.